Key result
Translational frameworks using biomarkers and AI guide precision interventions against inflammaging in age-related diseases.
Why the study?
Ongoing challenges remain in precisely defining and measuring inflammaging, a chronic sterile inflammatory state contributing to age-associated diseases that is shaped by modifiable factors.
This review synthesizes the current understanding of inflammaging, its mechanistic drivers, and its role in age-associated diseases, proposing a framework for biomarker signatures and precision interventions.
Increases relevance of inflammaging to geriatric CV care; leaves open targeted interventions pending randomized outcome trials.**[[1]](https://www.jacc.org/doi/10.1016/j.jacc.2021.12.017)[[2]](https://www.sciencedirect.
Inflammaging refers to the chronic, low-grade, sterile inflammatory state that emerges as a hallmark of biological aging and is increasingly recognized as a contributor to functional decline, frailty, and the progression of multiple age-associated diseases. While acute inflammation supports host defense and tissue repair, persistent and unresolved inflammatory signaling promotes tissue damage, metabolic dysregulation, and impaired immune homeostasis. Inflammaging reflects a dysregulated physiological state associated with elevated damage-associated molecular patterns (DAMPs), pro-inflammatory cytokines, altered immune cell composition, metabolic imbalance, and the accumulation of senescent cells exhibiting a senescence-associated secretory phenotype (SASP). Together, these processes impair immune surveillance, increase oxidative stress, and tissue vulnerability, potentially accelerating functional decline and amplifying disease trajectories that may originate earlier in life. Despite ongoing challenges in precisely defining and measuring inflammaging, evidence suggests that its development is shaped not only by chronological aging but also by behavioral, environmental, psychosocial, and genetic factors, highlighting its dynamic and potentially modifiable nature. In this review, we distinguish inflammaging from general chronic inflammation, synthesize current understanding of its biological origins and mechanistic drivers, and examine its role in clinical outcomes including sarcopenia, neurodegeneration, and cardiovascular disease. We propose a conceptual translational framework linking biological mechanisms of inflammaging to multilayer biomarker signatures, AI-based risk stratification, and precision interventions. Additionally, we discuss the opportunities and limitations of these approaches for identifying individuals at risk for chronic disease and informing multi-dimensional strategies to promote resilience and extend health-span.
No takes yet. Share an insight, caveat, or question.
Zeidan et al. (2026) conducted a review in Inflammaging. Inflammaging, a chronic inflammatory state driving age-related diseases, can be targeted through a translational framework utilizing biomarker signatures, AI risk stratification, and precision interventions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: